Selective block of sarcolemmal IKATP in human cardiomyocytes using HMR 1098

Stefan Kääb, Ludwig Zwermann, Andreas Barth, Martin Hinterseer, Heinrich C. Englert, Heinz Gögelein, Michael Näbauer

Research output: Contribution to journalArticlepeer-review


Purpose: Activation of the myocardial, ATP-dependent potassium current (IKATP) during ischemia causes shortening of the action potential duration thereby increasing dispersion of repolarization between ischemic and non-ischemic myocardium and predisposing to reentrant arrhythmias. The IK ATP inhibitor HMR1098 allows selective block of the sarcolemmal myocardial KATP-channel in various animal species. Therefore, we studied the concentration and pH-dependence of HMR1098 in human ventricular myocytes. Methods: Human ventricular cardiomyocytes were isolated enzymatically. IKATP was measured with the patch-clamp technique in whole cell configuration at 35°C. Action potentials were recorded using Amphotericine B in perforated patch conditions. In voltage clamp experiments, the K ATP-channel was activated by application of 1μM rilmakalim, a KATP-channel opener. In action potential recordings, 0.1 μM rilmakalim was used. Results: At physiological pH (pH = 7.3) half-maximal block of the rilmakalim-induced current occurred at 0.42 ± 0.008 μM HMR1098 (at 0 mV membrane potential); under acidic conditions as can be expected to be present under ischemic conditions (pH = 6.5), half-maximal block was achieved at markedly lower concentrations (IC50 = 0.24 ± 0.009 μM). In current clamp experiments, block of IKATP by HMR1098 was capable of reversing the action potential shortening induced by rilmakalim, and restored the action potential plateau. Conclusions: HMR1098 appears to be useful to prevent IKATP-induced shortening of the action potential in human ventricular myocardium. More acidic conditions, as observed in ischemia, increase the sensitivity to HMR1098, indicating a more potent effect in ischemic myocardium. Thus, HMR1098 may be a useful agent to prevent action potential shortening and dispersion of repolarization during ischemia, which may protect against ischemia induced ventricular arrhythmias.

Original languageEnglish (US)
Pages (from-to)435-441
Number of pages7
JournalCardiovascular Drugs and Therapy
Issue number5-6
StatePublished - 2003
Externally publishedYes


  • ATP-dependent potassium current
  • Arrhythmia
  • Human cardiomyocytes
  • Patch clamp

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)


Dive into the research topics of 'Selective block of sarcolemmal IKATP in human cardiomyocytes using HMR 1098'. Together they form a unique fingerprint.

Cite this